Lewis S Blevins

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc An approach to the management of patients with residual Cushing's disease
    Lewis S Blevins
    California Center for Pituitary Disorders, University of California at San Francisco, Room A 808, San Francisco, CA 94143 0350, USA
    J Neurooncol 94:313-9. 2009
  2. doi request reprint Suprasellar Rathke cleft cysts: clinical presentation and treatment outcomes
    Matthew B Potts
    Department of Neurosurgery and California Center for Pituitary Disorders, University of California, San Francisco, California 94143 0112, USA
    Neurosurgery 69:1058-68; discussion 1068-7. 2011
  3. doi request reprint Utility of the immediate postoperative cortisol concentrations in patients with Cushing's disease
    Michael E Sughrue
    California Center for Pituitary Disorders, University of California, San Francisco, California 94143 0350, USA
    Neurosurgery 67:688-95; discussion 695. 2010
  4. doi request reprint Excess mortality for patients with residual disease following resection of pituitary adenomas
    Michael E Sughrue
    California Center for Pituitary Disorders, University of California, 400 Parnassus Avenue, Room A 808, San Francisco, CA 94143 0350, USA
    Pituitary 14:276-83. 2011
  5. pmc Long term outcome following repeat transsphenoidal surgery for recurrent endocrine-inactive pituitary adenomas
    Edward F Chang
    Department of Neurological Surgery, University of California at San Francisco, San Francisco, CA, USA
    Pituitary 13:223-9. 2010
  6. ncbi request reprint Use of intravenous conivaptan in neurosurgical patients with hyponatremia from syndrome of inappropriate antidiuretic hormone secretion
    Matthew B Potts
    Department of Neurological Surgery, University of California, San Francisco, California 94143 0112, USA
    Neurosurgery 69:268-73. 2011
  7. doi request reprint Extreme correction of hyponatremia in a patient treated with intravenous conivaptan
    Michael E Sughrue
    California Center for Pituitary Disorders at University of California, San Francisco, 400 Parnassus Avenue, Room A 808, San Francisco, California 94143 0350, USA
    J Clin Neurosci 17:1331-4. 2010

Detail Information

Publications7

  1. pmc An approach to the management of patients with residual Cushing's disease
    Lewis S Blevins
    California Center for Pituitary Disorders, University of California at San Francisco, Room A 808, San Francisco, CA 94143 0350, USA
    J Neurooncol 94:313-9. 2009
    ....
  2. doi request reprint Suprasellar Rathke cleft cysts: clinical presentation and treatment outcomes
    Matthew B Potts
    Department of Neurosurgery and California Center for Pituitary Disorders, University of California, San Francisco, California 94143 0112, USA
    Neurosurgery 69:1058-68; discussion 1068-7. 2011
    ..Rathke cleft cysts (RCCs), benign remnants of the Rathke pouch typically arising in the sella, sometimes have suprasellar extension. Purely suprasellar RCCs are rarely reported...
  3. doi request reprint Utility of the immediate postoperative cortisol concentrations in patients with Cushing's disease
    Michael E Sughrue
    California Center for Pituitary Disorders, University of California, San Francisco, California 94143 0350, USA
    Neurosurgery 67:688-95; discussion 695. 2010
    ..Several investigators have recommended serial measurements of serum cortisol in the days following pituitary surgery to identify patients at risk of recurrence...
  4. doi request reprint Excess mortality for patients with residual disease following resection of pituitary adenomas
    Michael E Sughrue
    California Center for Pituitary Disorders, University of California, 400 Parnassus Avenue, Room A 808, San Francisco, CA 94143 0350, USA
    Pituitary 14:276-83. 2011
    ....
  5. pmc Long term outcome following repeat transsphenoidal surgery for recurrent endocrine-inactive pituitary adenomas
    Edward F Chang
    Department of Neurological Surgery, University of California at San Francisco, San Francisco, CA, USA
    Pituitary 13:223-9. 2010
    ..Our data suggest that when performed by experienced transsphenoidal surgeons, durable tumor control can be obtained in these frequently locally aggressive tumors with acceptable rates of post-operative morbidity...
  6. ncbi request reprint Use of intravenous conivaptan in neurosurgical patients with hyponatremia from syndrome of inappropriate antidiuretic hormone secretion
    Matthew B Potts
    Department of Neurological Surgery, University of California, San Francisco, California 94143 0112, USA
    Neurosurgery 69:268-73. 2011
    ..Conivaptan is an arginine vasopressin receptor antagonist that has been shown to be both safe and effective in the treatment of euvolemic and hypervolemic hyponatremia...
  7. doi request reprint Extreme correction of hyponatremia in a patient treated with intravenous conivaptan
    Michael E Sughrue
    California Center for Pituitary Disorders at University of California, San Francisco, 400 Parnassus Avenue, Room A 808, San Francisco, California 94143 0350, USA
    J Clin Neurosci 17:1331-4. 2010
    ..Thus, the exact clinical situation should be taken into consideration, especially in cases of subacute to chronic hyponatremia, where such an extreme correction could lead to neurologic devastation...